论文部分内容阅读
目的探讨颅内血肿微创清除术联合脑血疏口服液治疗高血压脑出血的疗效。方法选取2010年10月-2012年7月常规微创颅内血肿清除术治疗的40例高血压脑出血患者为对照组,同期采用常规微创颅内血肿清除术加脑血疏口服液进行治疗的46例患者为观察组,两组患者治疗前及治疗后2周、4周的神经功能缺损程度及Barthal指数进行评估及比较。结果治疗后2周及4周观察组的神经功能缺损轻型率高于对照组,Barthal指数≥75分比例也高于对照组,P均<0.05,差异有统计学意义。结论颅内血肿微创清除术联合脑血疏口服液治疗高血压脑出血的疗效较佳,可有效地改善患者的神经功能缺损程度及生存能力。
Objective To investigate the curative effect of intracranial hematoma minimally invasive surgery combined with NaoxueShu oral liquid on hypertensive intracerebral hemorrhage. Methods Forty patients with hypertensive intracerebral hemorrhage who underwent routine minimally invasive intracranial hematoma resection from October 2010 to July 2012 were selected as the control group and treated with conventional minimally invasive intracranial hematoma and Naoxueshu oral liquid Of 46 patients were observed, the two groups of patients before and after treatment, 2 weeks, 4 weeks after the degree of neurological deficit and Barthal index were evaluated and compared. Results After 2 and 4 weeks of treatment, the rate of neurological deficit in the observation group was higher than that of the control group. The Barthal index ≥75 score was also higher than the control group, P <0.05, the difference was statistically significant. Conclusion The minimally invasive intracranial hematoma removal combined with cerebral blood sparse oral liquid treatment of hypertensive intracerebral hemorrhage better effect, which can effectively improve the degree of patients with neurological deficits and viability.